5 min read
How to Overcome 5 Big Dispensary Problems
Even as the cannabis industry matures, dispensaries still face a handful of stubborn challenges rooted in the gap between state legalization and federal law. These problems are fairly universal, but real developments and tools can help. Here are the major issues standing in the way of dispensaries in 2026, with practical remedies for each.
Five Problems and Practical Fixes
| Problem | Where it stands in 2026 | Practical remedy |
|---|---|---|
| Banking | Reintroduced in June 2026 as the SAFE Banking Act of 2026; still pending in Congress | State-chartered banks, fintech, and audit-ready POS records |
| Security | Strict state surveillance and retention mandates | Compliant cameras, access control, and cybersecurity |
| The Feds | State-federal gap persists; rescheduling under review | Operate as if change is gradual, stay fully compliant |
| Classification | State-licensed medical marijuana moved to Schedule III in April 2026; broader rescheduling still pending after the summer 2026 DEA hearing | Track the process; prepare for 280E relief if it lands |
| Black Market | Illicit sales still undercut taxed legal product | Compete on quality, safety, and consistent service |
Dispensary Banking
Banking remains the number one problem for dispensaries. Cannabis businesses generate large amounts of cash, yet many federally insured banks still take a hands-off approach because cannabis is not fully legal at the federal level. The SAFER Banking Act, which would protect financial institutions that serve state-legal cannabis businesses, has repeatedly stalled in Congress despite bipartisan support, so the issue is far from resolved. In June 2026 the bill was reintroduced in both chambers as the SAFE Banking Act of 2026, and the Senate version was referred to the Committee on Banking, Housing, and Urban Affairs. In the meantime, more state-chartered banks, credit unions, and specialized fintech providers have stepped in. Dispensaries should document every transaction to build the relationship and stay audit-ready. This is especially valuable in fast-growing markets like New Jersey’s adult-use cannabis market, where operators compete for limited banking partners.
Dispensary Security
Security is a constant concern because people go to great lengths to steal product and cash. Nearly every legal state imposes strict security regulations, from video surveillance to reinforced doors and access control. Surveillance hardware and reinforced construction can be pricey, and data storage is a significant ongoing cost, since most states require surveillance footage to be retained for 30 to 90 days. Cybersecurity is equally critical: a compromised point-of-sale system can expose sensitive customer data. As one example (and, full disclosure, our own product), IndicaOnline stores data in maximum-security storage centers in multiple locations and uses 256-bit SSL encryption, as described in our overview of dispensary software security measures. With legality comes regulation, so investing in security now saves thousands down the road.
The Feds
Make no mistake: cultivating and selling cannabis remains illegal at the federal level, even as 24 states and Washington, DC had legalized adult use as of April 2026. This federal-state conflict is the root cause of the banking and security hurdles above, since it makes large financial and security institutions wary of entering the industry. The most effective response is collective action: supporting industry associations and advocates pushing for sensible federal reform, while staying fully state compliant in the meantime. Momentum has grown considerably, with rescheduling now under active federal review, but operators should run their businesses as if federal change is gradual rather than guaranteed.
Cannabis Classification
Since April 2026, federal law treats cannabis in two tiers: FDA-approved marijuana products and marijuana subject to a state medical marijuana license are in Schedule III of the Controlled Substances Act, while all other marijuana remains in Schedule I. Broader rescheduling may still be coming. On May 21, 2024, the Department of Justice formally proposed moving marijuana from Schedule I to Schedule III, following an August 2023 recommendation from Health and Human Services. The broader process has moved slowly: a DEA administrative hearing ran from June 29 to July 15, 2026, and as of this November 2026 update, motions from opponents had delayed the judge’s recommendation, with the DEA Administrator’s final decision still to come (see this status overview). Rescheduling removes Section 280E as a bar to deductions and credits for businesses that, under the April 2026 order, no longer traffic in Schedule I or II substances, though the order states it is not a determination of federal tax liability, so licensees should consult tax counsel. Broader reclassification to Schedule III would be historic: it would extend 280E relief to more cannabis businesses and open the door to far more research. Importantly, rescheduling is not full legalization, and industry groups note it would not automatically solve banking access, so dispensaries should watch the process closely while continuing to operate under current rules. Operators in newer medical markets like Arkansas’ medical cannabis program have a particular stake in how federal research and tax rules evolve.
An Honest Take
It is tempting to read every rescheduling headline as the moment the industry’s problems finally dissolve, but the operators who thrive treat federal reform as a slow-moving tailwind, not a rescue. Banking, security, and the illicit market are challenges you can act on today — clean financial records, compliant systems, and a genuinely better customer experience than the corner dealer offers. Build the business as if nothing in Washington will change this year, and any reform that does arrive becomes a bonus rather than the foundation you were counting on.
The Black Market
An illicit market persists alongside every regulated product, and cannabis is no exception. The unregulated market targets those who can’t or won’t buy legally, including minors, and sells untested product that can be tainted or mislabeled. This is the real danger of black-market cannabis.
High taxes and limited licensing can unintentionally keep the illicit market alive by making legal product more expensive. The long-term solution combines fair regulation, competitive legal pricing, and consistent enforcement against bad actors. Licensed dispensaries help by maintaining rigorous compliance, verifying every customer’s age, and tracking inventory through seed-to-sale systems like Metrc so legal product never leaks into illegal channels. A reliable inventory management system is one of the best defenses a compliant dispensary has.